NCT06520098
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06520098
Title A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) (Benefit VA)
Acronym Benefit VA
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors VA Office of Research and Development
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
San Francisco VA Medical Center, San Francisco, CA RECRUITING San Francisco California 94121-1563 United States Details
Kansas City VA Medical Center, Kansas City, MO RECRUITING Kansas City Missouri 64128-2226 United States Details
Durham VA Medical Center, Durham, NC RECRUITING Durham North Carolina 27705-3875 United States Details
VA Puget Sound Health Care System Seattle Division, Seattle, WA RECRUITING Seattle Washington 98108-1532 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field